Paclitaxel (Taxol) and Taxoid Derivates for Lung Cancer Treatment: Potential for Aerosol Delivery

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|3|4|287-296

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.3, Iss.4, 2003-01, pp. : 287-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aerosol Delivery in the Treatment of Lung Cancer

By  

Current Cancer Drug Targets, Vol. 15, Iss. 7, 2015-01 ,pp. : 604-612

Bentham Science Publishers

Access to resources Recommend Favorite

Camptothecins and Lung Cancer: Improved Delivery Systems by Aerosol

By  

Current Cancer Drug Targets, Vol. 3, Iss. 4, 2003-08 ,pp. : 251-264

Bentham Science Publishers

Access to resources Recommend Favorite

The Re-Emergence of Aerosol Gene Delivery: A Viable Approach to Lung Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 3, Iss. 4, 2003-08 ,pp. : 275-286

Bentham Science Publishers

Access to resources Recommend Favorite

Establishment of a Paclitaxel Resistant Human Breast Cancer Cell Strain (MCF-7/Taxol) and Intracellular Paclitaxel Binding Protein Analysis

By Zuo K-Q   Zhang X-P   Zou J   Li D   Lv Z-W  

The Journal of International Medical Research, Vol. 38, Iss. 4, 2010-07 ,pp. : 1428-1435

Field House Publishing

Access to resources Recommend Favorite

Treatment of Lung Cancer Using Nanoparticle Drug Delivery Systems

By  

Current Drug Discovery Technologies, Vol. 10, Iss. 2, 2013-06 ,pp. : 170-176

Bentham Science Publishers

Access to resources Recommend Favorite